Mary Jande

Mary Jande

UNVERIFIED PROFILE

Are you Mary Jande?   Register this Author

Register author
Mary Jande

Mary Jande

Publications by authors named "Mary Jande"

Are you Mary Jande?   Register this Author

9Publications

214Reads

19Profile Views

Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications.

Expert Rev Clin Pharmacol 2017 Nov 5;10(11):1263-1271. Epub 2017 Sep 5.

c Strathclyde Institute of Pharmacy and Biomedical Sciences , Strathclyde University , Glasgow , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2017.1371590DOI Listing
November 2017

Patient-related beliefs and adherence toward their medications among the adult hypertensive outpatients in Tanzania.

J Comp Eff Res 2017 May 9. Epub 2017 May 9.

School of Pharmacy, Catholic University of Health & Allied Science, PO Box 1464 Mwanza, Tanzania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2016-0060DOI Listing
May 2017

4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians.

Pharmacogenet Genomics 2008 Mar;18(3):201-8

Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3282f50ee9DOI Listing
March 2008

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population.

Pharmacogenet Genomics 2006 Sep;16(9):637-45

Department of Clinical Toxicology, Central Laboratories & Blood Bank, King Fahad Medical City, Riyadh 11525, Kingdom of Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.fpc.0000230411.89973.1bDOI Listing
September 2006

Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.

Eur J Clin Pharmacol 2005 Nov 29;61(10):755-61. Epub 2005 Oct 29.

African Institute of Biomedical Science & Technology (AIBST), P.O. Box 2294, Harare, Zimbabwe.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-005-0037-3DOI Listing
November 2005

Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Clin Pharmacol Ther 2005 Apr;77(4):259-70

Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 171 77 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clpt.2004.11.003DOI Listing
April 2005